GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clearmind Medicine Inc (NAS:CMND) » Definitions » 5-Year Yield-on-Cost %

Clearmind Medicine (Clearmind Medicine) 5-Year Yield-on-Cost % : 0.00 (As of Jun. 19, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Clearmind Medicine 5-Year Yield-on-Cost %?

Clearmind Medicine's yield on cost for the quarter that ended in Jan. 2024 was 0.00.


The historical rank and industry rank for Clearmind Medicine's 5-Year Yield-on-Cost % or its related term are showing as below:



CMND's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.875
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Clearmind Medicine's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Clearmind Medicine's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clearmind Medicine's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clearmind Medicine's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Clearmind Medicine's 5-Year Yield-on-Cost % falls into.



Clearmind Medicine 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Clearmind Medicine is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Clearmind Medicine  (NAS:CMND) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Clearmind Medicine 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Clearmind Medicine's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Clearmind Medicine (Clearmind Medicine) Business Description

Traded in Other Exchanges
Address
101-1220 West 6th Avenue, Vancouver, BC, CAN, V6H 1A5
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

Clearmind Medicine (Clearmind Medicine) Headlines